Showing results (331-340 of 369) with videos related to
Sort By:
Pageof 37
Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.Cancer|April 30, 2020
Breast cancer early detection: A phased approach to implementationOphira Ginsburg, Cheng-Har Yip, Ari Brooks, et al.Clinical Lung Cancer|November 9, 2020
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab MonotherapyGiannis Mountzios, Alessandro de Toma, Panagiota Economopoulou, et al.Expert Review of Molecular Diagnostics|September 27, 2021
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancerUmberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)Jair Bar, Nir Peled, Shiruyeh Schokrpur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.Future Oncology (London, England)|November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summaryGrace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape ProjectStephen P Finn, Alfredo Addeo, Urania Dafni, et al.Lung Cancer (Amsterdam, Netherlands)|May 1, 2025
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trialMatthias Guckenberger, Isabelle Opitz, Tereza Dellaporta, et al.The Laryngoscope|July 23, 2025
Head and Neck Cancer in Southeast Asia: 2022 Incidence, Mortality, and Projections to 2050Jenny Chen, Aryan Selokar, Frances Dominique V Ho, et al.Pageof 37